Zurueck zur Suche

Reporte zur Charge U024505

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

19Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
OK 7 MA 2 GA 1 ID 1 OH 1 FL 1 WA 1 NH 1 AR 1 IL 1 NC 1 TX 1

VAERS 2287380

MERCK & CO. INC. · HEP A (VAQTA) · Charge U024505

schwer
Staat
GA
Alter
1,1
Geschlecht
M
Eingang
20.05.2022
Impfdatum
18.05.2022
Beginn
18.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Crying Febrile convulsion Irritability Pain Posture abnormal Pyrexia Rash Rash erythematous

Symptomtext

broke out in bright red confluent rash that started on the face and spread to rest of the body within 1hr- and then high fever - tmax 104.4 occurred about 1 hour after rash started-and holding head like pain - very irritable and hard to console - also had febrile seizure

Weitere VAERSDATA-Felder
Praegender Schweregrund
Febrile convulsion
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
anemia- prematurity
Andere Medikamente
loratadine
Allergien
NKDA no known allergies to foods or other items- no allergy testing done to present
Vorherige Impfungen
-

VAERS 2137226

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge U024505

schwer
Staat
ID
Alter
6,0
Geschlecht
M
Eingang
24.02.2022
Impfdatum
24.02.2022
Beginn
24.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope

Symptomtext

Patient fainted twice, was evaluated by a provider both times.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none known
Vorherige Impfungen
-

VAERS 2250435

MERCK & CO. INC. · HEP A (VAQTA) · Charge U024505

mild
Staat
OH
Alter
1,2
Geschlecht
M
Eingang
25.04.2022
Impfdatum
22.04.2022
Beginn
23.04.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Pyrexia Rash Rash papular

Symptomtext

Patient developed fever of 100.5 and a papular rash on the face and upper chest on 04/23/2022. The rash worsened over the weekend and by the time he was seen in the office on Monday had become more confluent especially on his cheeks and chest. no vesicles. No crusting or drainage. No urticaria. No wheezing or respiratory distress. continued low grade fevers that did respond to antipyretics but would return. He was more tired than usual but no Koplic spots, conjunctivitis, or lymphadenopathy. there were no meningeal signs at the time seen in the office. Course of the antibiotic was completed on the day before the onset of the rash per mom. He did receive the Hepatitis A and Prevnar 13 vaccine on 04/22/2022. Rash is consistent with Measles rash or possibly allergic reaction although not likely. Was NOT consistent with parvovirus B19 or Enteroviral rash

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
none at the time of this report.
Aktuelle Erkrankungen
left acute suppurative otitis media
Vorgeschichte
none
Andere Medikamente
Amoxil
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2198757

MERCK & CO. INC. · HEP A (VAQTA) · Charge U024505

mild
Staat
FL
Alter
2,0
Geschlecht
M
Eingang
25.03.2022
Impfdatum
23.03.2022
Beginn
25.03.2022
Tage bis Beginn
2,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Diarrhoea Gastrointestinal disorder Illness Pyrexia Vomiting

Symptomtext

mom called in am on 3/25 stating child developed fever, vomiting (x 1), and diarrhea in the am. no previous reaction to vaccine. widespread community GI illness based on recent medical visits and parent calls. patient is not in childcare. home treatment for symptoms given with advice to call for appt if worsening symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none known
Vorgeschichte
none known
Andere Medikamente
none known
Allergien
none known
Vorherige Impfungen
-

VAERS 2664293

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge U024505

gering
Staat
WA
Alter
3,0
Geschlecht
M
Eingang
01.08.2023
Impfdatum
11.07.2022
Beginn
11.07.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration

Symptomtext

Patient received dose two of their Hepatitis A vaccine too soon.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2627666

MERCK & CO. INC. · HEP A (VAQTA) · Charge U024505

gering
Staat
MA
Alter
7,0
Geschlecht
M
Eingang
05.05.2023
Impfdatum
12.01.2022
Beginn
12.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Circumstance or information capable of leading to medication error Extra dose administered No adverse event

Symptomtext

HCP called to report that she accidentally gave the patient an extra dose of VARIVAX. No additional AE/PQC; HCP called to report that she accidentally gave the patient an extra dose of VARIVAX. No additional AE/PQC; third dose of VAQTA on 6/21/2022; fourth dose of MMR II on 4/19/2022; third dose of MMR II on 1/12/2022; This spontaneous report was received from a registered nurse and refers to a 7-year-old male patient with milk protein and soy allergies, neonatal abstinence syndrome, neonatal stroke, attention deficit hyperactivity disorder (ADHD), and autism. His medical history was not reported. Concomitant medications included sterile diluent (STERILE DILUENT), diphtheria vaccine toxoid (+) pertussis vaccine acellular (+) tetanus vaccine toxoid (DTAP) and hepatitis b vaccine (HEP-B-VAX). He had no adverse event following prior vaccination. On an unknown date, the patient was vaccinated with the third dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U030162, expiration date: 28-SEP-2023, administered subcutaneously in right arm (dose was not provided). On 12-JAN-2022, he was administered with the third dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, 0.5 milliliter, lot #T033815, expiration date: 05-OCT-2022, administered subcutaneously in right arm (extra dose administered). Then, on 19-APR-2022, he received the fourth dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, 0.5 milliliter, lot #T034392, expiration date: 08-OCT-2022, administered subcutaneously in right arm (extra dose administered). On that date, the patient was also administered with polio vaccine. On 21-JUN-2022, the patient received the third dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 0.5 milliliter, lot #U024505, expiration date: 15-OCT-2022, administered intramuscularly in left deltoid (extra dose administered). The HCP said the patient went to a different pediatrician in 2022, and the pediatrician was unsure of the patient's vaccination history. So, due to the unknown vaccination history (incomplete and inaccurate vaccine documentation), the patient received these extra doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and hepatitis a vaccine, inactivated (VAQTA) in 2022. On 06-APR-2023, the patient was accidentally vaccinated with the fourth dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #W024335, expiration date: 01-AUG-2024, administered subcutaneously in left arm (extra dose administered). All vaccines were administered for prophylaxis. No adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Circumstance or information capable of leading to medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Attention deficit hyperactivity disorder; Autism; Milk protein allergy; Neonatal abstinence syndrome; Perinatal stroke; Prophylaxis; Soy allergy
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT; DTAP; HEP-B-VAX
Allergien
-
Vorherige Impfungen
-

VAERS 2489377

MERCK & CO. INC. · HEP A (VAQTA) · Charge U024505

gering
Staat
NH
Alter
0,8
Geschlecht
U
Eingang
26.10.2022
Impfdatum
18.10.2022
Beginn
18.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

No additional AE reported; 9 Month Old Patient was administered expired VAQTA on 10/18/2022; This spontaneous report has been received from a nurse, concerning 9-months-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, and concomitant medications were not provided. On 18-10-2022, the patient was vaccinated with expired hepatitis a vaccine, inactivated (VAQTA) intramuscular injection (valid lot number U024505 [expiration date 15-OCT-2022]) for prophylaxis (expired product administered). No previous temperature excursion was reported. No additional adverse events (AE) were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2418431

MERCK & CO. INC. · HEP A (VAQTA) · Charge U024505

gering
Staat
AR
Alter
1,6
Geschlecht
F
Eingang
23.08.2022
Impfdatum
17.08.2022
Beginn
23.08.2022
Tage bis Beginn
6,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blister Erythema Immunisation reaction Product administered to patient of inappropriate age Skin erosion Wrong product administered

Symptomtext

Received a Tdap vaccine instead of a Dtap vaccine on 8/17/2022, developed a small raw, blistered area to left flank on 8/19/2022. Mother thought might of been a reaction to diaper so stopped using those types of diapers and switched to hypoallergenic and cloth diapers. The blister continued to enlarge and several small blisters formed around the initial blister and continues to worsen. Area does not appear infected but does have some erythremia surrounding blisters. Would of thought was a diaper reaction but continued to worsen after changing diapers, do suspect this is a reaction to Tdap vaccine. Discussed and doctor assessed area as well and in agreement with assessment. Admin Dec 2mg IM in office, advised to use Benadryl as needed, and apply Silvadene to area daily.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Blister
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 2338749

MERCK & CO. INC. · HEP A (VAQTA) · Charge u024505

gering
Staat
OK
Alter
1,1
Geschlecht
M
Eingang
28.06.2022
Impfdatum
21.06.2022
Beginn
21.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product storage error

Symptomtext

Patient was given vaccine after temperature excursion , vaccines exposed to above range temperatures

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2287044

MERCK & CO. INC. · HEP A (VAQTA) · Charge U024505

gering
Staat
IL
Alter
15,0
Geschlecht
F
Eingang
08.06.2022
Impfdatum
24.03.2022
Beginn
25.03.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age Wrong product administered

Symptomtext

WRONG VACCINE GIVEN HEP B ORDERED HEP A ADMISTERED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NO
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 2282956

MERCK & CO. INC. · HEP A (VAQTA) · Charge U024505

gering
Staat
MA
Alter
20,0
Geschlecht
M
Eingang
18.05.2022
Impfdatum
18.05.2022
Beginn
18.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Underdose

Symptomtext

Pt's was given wrong dose. He received 0.5mL when he was supposed to get 1mL . I left message on machine to call office back X 2 . If I don't hear back today I will send a letter to have him come in an get the correct dose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Underdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NO
Vorgeschichte
NO
Andere Medikamente
NO
Allergien
Amoxicillin
Vorherige Impfungen
-

VAERS 2264612

MERCK & CO. INC. · HEP A (VAQTA) · Charge U024505

gering
Staat
NC
Alter
1,5
Geschlecht
F
Eingang
05.05.2022
Impfdatum
30.03.2022
Beginn
30.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Erythema Swelling face

Symptomtext

Fifteen minutes after patient received Hep A, mom reports spots on face, facial swelling and redness. Symptoms lasted one hour. Mom gave Benadryl and took patient to the Emergency Room. No other interventions were done.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Eczema
Andere Medikamente
None
Allergien
Amoxicillin and Strawberries
Vorherige Impfungen
Per mom, patient had facial redness, puffiness and rash. Patient was 15 months and the vaccines that were given on 12/17/2021 we

VAERS 2211050

MERCK & CO. INC. · HEP A (VAQTA) · Charge U024505

gering
Staat
TX
Alter
5,0
Geschlecht
F
Eingang
31.03.2022
Impfdatum
28.03.2022
Beginn
28.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

VIS given to mother. Verified with provider. Kept tp 10-15 mins. no a/r.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
NO KNOWN ALLERGIES
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
itching~Hep B (no brand name)~1~5.00~Patient

VAERS 2118362

MERCK & CO. INC. · HEP A (VAQTA) · Charge U024505

gering
Staat
OK
Alter
-
Geschlecht
U
Eingang
17.02.2022
Impfdatum
04.01.2022
Beginn
04.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

Patient had no known side effects; Vaccine Coordinator reported a temperature excursion for VAQTA which was supported. Caller reported that 1 dose of VAQTA was administered to a patient.; This spontaneous report was received from a vaccine coordinator, referring to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided. On 04-JAN-2022, the patient was vaccinated with a 1 dose of improperly stored hepatitis a vaccine, inactivated (VAQTA) (lot # U024505, expiration date: 15-OCT-2022; strength, route and site of administration were not provided) for prophylaxis (product storage error). Temperature excursion for hepatitis a vaccine, inactivated (VAQTA) was supported. The patient had no known side effects (no adverse event). This is one of several reports received from the same reporter. ; Sender's Comments: US-009507513-2201USA006297:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2103849

MERCK & CO. INC. · HEP A (VAQTA) · Charge U024505

gering
Staat
OK
Alter
-
Geschlecht
U
Eingang
11.02.2022
Impfdatum
03.01.2022
Beginn
03.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse event; temperature excursion for VAQTA; This spontaneous report was received from a vaccine coordinator and refers to a patient of unknown age and gender. No information regarding patient's medical history, concurrent conditions or concomitant therapies was provided. On 03-JAN-2022, the patient was vaccinated with an improperly stored hepatitis a vaccine, inactivated (VAQTA) lot # U024505, expiration date 15-OCT-2022 (dose, dose number and site of administration were not provided) for prophylaxis (Product storage error) . No details regarding time and conditions were provided for the temperature excursion. No adverse events were reported (No adverse event). This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-2201USA006297: US-009507513-2201USA005595: US-009507513-2201USA005673: US-009507513-2201USA005751: US-009507513-2201USA005901: US-009507513-2201USA006305: US-009507513-2201USA006322: US-009507513-2201USA006342: US-009507513-2201USA006419: US-009507513-2201USA006445: US-009507513-2201USA006536:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2101013

MERCK & CO. INC. · HEP A (VAQTA) · Charge U024505

gering
Staat
OK
Alter
-
Geschlecht
U
Eingang
10.02.2022
Impfdatum
-
Beginn
30.12.2021
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

no known side effects; temperature excursion for VAQTA; This spontaneous report was received from a vaccine coordinator and refers to a patient of an unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 30-DEC-2021, the patient received incorrectly stored hepatitis a vaccine, inactivated (VAQTA), 1 dosage form, lot #U024505, expiration date: 15-OCT-2022, administered for prophylaxis (route of administration was not provided). No known side effects were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2089711

MERCK & CO. INC. · HEP A (VAQTA) · Charge U024505

gering
Staat
OK
Alter
-
Geschlecht
U
Eingang
05.02.2022
Impfdatum
04.01.2022
Beginn
04.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Patient had no known side effects; Vaccine Coordinator reported a temperature excursion for VAQTA which was supported. Caller reported that 1 dose of VAQTA was administered to a patient.; This spontaneous report was received from a vaccine coordinator and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history or concomitant therapy provided. On 04-JAN-2022, the patient was vaccinated with improperly stored 1 dose hepatitis a vaccine, inactivated (VAQTA) prefilled syringe, lot # U024505, expiration date 15-OCT-2022 (exact dose, route of administration and anatomical location were not provided) for prophylaxis (product storage error). It was reported that a temperature excursion for hepatitis a vaccine, inactivated (VAQTA) was supported. No details provided. The patient had no known side effects (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2089710

MERCK & CO. INC. · HEP A (VAQTA) · Charge U024505

gering
Staat
OK
Alter
-
Geschlecht
U
Eingang
05.02.2022
Impfdatum
03.01.2022
Beginn
03.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Patient had no known side effects; Vaccine Coordinator reported a temperature excursion for VAQTA which was supported; This spontaneous report was received from a vaccine coordinator and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions or medical history provided. On 03-JAN-2022, the patient was vaccinated with incorrectly stored hepatitis a vaccine, inactivated (VAQTA) lot # U024505, expiration date 15-OCT-2022 (formulation, dose, route of administration, anatomical location were not reported) for prophylaxis (product storage error). The patient had no known side effects (no adverse event). This is one of several cases received from the same reporter. ; Sender's Comments: US-009507513-2201USA005595: US-009507513-2201USA005673: US-009507513-2201USA005751: US-009507513-2201USA005901: US-009507513-2201USA006295: US-009507513-2201USA006305: US-009507513-2201USA006322: US-009507513-2201USA006342: US-009507513-2201USA006419: US-009507513-2201USA006445: US-009507513-2201USA006536:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2067685

MERCK & CO. INC. · HEP A (VAQTA) · Charge U024505

gering
Staat
OK
Alter
-
Geschlecht
U
Eingang
27.01.2022
Impfdatum
05.01.2022
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Reported a temperature excursion for VAQTA which was supported; Patient had no known side effects; Information has been received regarding a patient of unknown age and gender. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported. On 05-JAN-2022, the patient was vaccinated with 1 dose of hepatitis a vaccine, inactivated (VAQTA) lot # U024505 with expiration date on 15-OCT-2022, for prophylaxis (strength, route of administration and anatomical location were not provided) that underwent a temperature excursion. Patient had no known side effects.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-